Anand Sivaraman

Anand Sivaraman is the founder and managing director of Remidio, a company that develops artificial intelligence-driven systems for glaucoma detection. He emphasizes the growing threat of glaucoma in South and Southeast Asia, where genetic predispositions and smaller eye sizes increase vulnerability to the disease. Sivaraman advocates for the use of AI tools to enhance early detection and management of glaucoma, particularly in underserved areas of India, where access to specialized medical care is limited.